This thesis presents a comprehensive study on the pharmaceutical development of vaccines, focusing on scientific, technical, and regulatory processes. It covers key aspects such as antigen selection, adjuvant formulation, clinical trials, manufacturing, and global distribution. Special emphasis is placed on innovative technologies like mRNA platforms and the challenges of vaccine accessibility and hesitancy. The research aims to highlight both current advancements and future directions in vaccinology, contributing to improved public health strategies worldwide.